Skip to main content
. 2014 Dec 12;4(1):1–19. doi: 10.1007/s40123-014-0027-6

Fig. 3.

Fig. 3

Proportion of eyes with an improvement (left panel) or deterioration (right panel) in visual acuity from baseline of at least 0.30 logMAR at 3 years in the 0.59- and 2.1-mg implant groups. (P values for the within-treatment comparison of study eye versus fellow eye). *P < 0.0001. P = 0.0046. logMAR logarithm of the minimum angle resolution